Immuno-10

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameImmuno-10
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionTumor necrosis factor modulators
TargetsTumor necrosis factor
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUnigen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnigen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A